Results 181 to 190 of about 14,383,405 (370)
Estimating wage disparities using foundation models. [PDF]
Proc Natl Acad Sci U S AVafa K, Athey S, Blei DM.
europepmc +1 more source
Molecular Oncology, EarlyView.This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci +6 more
wiley +1 more source
Researches into the early history of mankind and the development of civilization.
, 1878 Edward B. Tylor
openalex +2 more sources
Landscape of BRAF transcript variants in human cancer
Molecular Oncology, EarlyView.We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda +5 more
wiley +1 more source
Migracions, canvi cultural i ciutadania a Catalunya (1920-1980)
Cercles: revista d'Història Cultural, 2016 Intellectual and Cultural History Group GEHCI
doaj
Contributions to the natural history of the United States of America / by Louis Agassiz.
Louis Agassiz
openalex +2 more sources
Creeds and ConfessionsA History of Creeds and Confessions of Faith in Christendom and beyond. William A. Curtis [PDF]
, 1912 J. W. Moncrief
openalex +1 more source
Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer
Molecular Oncology, EarlyView.G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren +16 more
wiley +1 more source